In the cannabis space this week, retailer Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) told investors it will be entering the US market through a novel strategic action.

Meanwhile, two longstanding cannabis partners ended their relationship.


Keep reading to find out more cannabis highlights from the past five days.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Following US listing application, retailer pursues American marketplace

Fire & Flower said on Monday (February 22) that it will license its store brand, store operating system and Hifyre technology platform for the set up of dispensaries in California, Arizona and Nevada via a private company operating as American Acres Managers.

“Securing an agreement that will rapidly place Fire & Flower licensed stores in the United States is the first step in executing our vision well ahead of federal legalization in the United States,” CEO Trevor Fencott said in a statement.

The US market has quickly gained steam as the most in-demand sector to cover for Canadian cannabis companies as chatter has picked up about potential policy changes for the country.

The company went as far as to say it anticipates that the first Fire & Flower store will open in the initial half of the 2021 fiscal period in Palm Springs, California.

Canopy Growth closes relationship with spin-off company

A previously announced separation deal between former partners Canopy Growth (NASDAQ:CGC,TSX:WEED) and RIV Capital (TSX:RIV,OTC:CNPOF), formerly known as Canopy Rivers, was completed this past week.

As part of the transaction, Canopy Growth will walk away with a 20 percent stake in TerrAscend (CSE:TER,OTCQX:TRSSF), a cannabis operator with US assets. However, Canopy Growth can’t exercise the shares it owns in the company until there is a change in federal permissions for cannabis in the US.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

For RIV Capital, this now means the company is free to fully pursue investments in the US cannabis market. “We believe that the evolving regulatory environment and market conditions make now an ideal time to enter the US, the most attractive cannabis market in the world,” Narbé Alexandrian, president and CEO of RIV Capital, said in a statement.

RIV Capital also told investors that the company “may initiate the process to de-list from the TSX and list its securities on a stock exchange that does not prohibit such investments or acquisitions at such time.”

Cannabis company news

  • The Valens Company (TSX:VLNS,OTCQX:VLNCF) issued fiscal results for Q4 2020 as well as the full year. “Moving into 2021 with a transformed business model … Valens is focused on three key initiatives — growing unit volumes per SKU, increasing Cannabis 2.0 and 3.0 product market share, and driving revenues in new consumer verticals,” Valens CEO Tyler Robson said.
  • High Tide (TSXV:HITI,OTCQB:HITIF) confirmed an update to its balance sheet. Raj Grover, president and CEO of High Tide, said the company’s financials have never been stronger. He added that the company will now go ahead and pursue potential acquisition deals.
  • Aphria (NASDAQ:APHA,TSX:APHA) and Tilray (NASDAQ:TLRY) jointly announced the launch of a website (www.aphriatilraytogether.com) to share details and updates with investors on the progress of their combination deal. “Together, Aphria and Tilray expect to have a robust strategic footprint in Canada and internationally with the operational scale necessary to compete more effectively in today’s consolidating cannabis market,” Aphria CEO Irwin Simon said.
  • Australis Capital (CSE:AUSA,OTCQB:AUSAF) completed its planned acquisition of a 51 percent stake in ALPS, which will lead to the appointment of Terry Booth as CEO once the deal closes.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less